secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001493152-23-013321
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma appoints Fred Hassan to board; he invests $2M in company
-------------------------------------------------------------------------

- Fred Hassan appointed to Board of Directors on April 20, 2023, increasing board to six members.
- Hassan invested $2 million in Cocrystal, purchasing 1,015,229 shares alongside director Phillip Frost.
- Hassan brings 40-year pharma industry experience, having served as CEO of Schering-Plough and Pharmacia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315223013321/0001493152-23-013321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315223013321/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-013321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer